BD Onclarity™ HPV Assay with extended genotyping

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD Onclarity™ HPV Assay with extended genotyping
Cervical Cancer | Brochures
BD Onclarity™ HPV Assay with extended genotyping
BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.
Cervical Cancer | News & Updates
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
Politico article
Cervical Cancer | News & Updates
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds